Ursodeoxycholic acid use is associated with significant risk of morbidity and mortality in infants with cholestasis: A strobe compliant study

The off-label use of medications is a “right” for pediatricians, owing to lack of enough safety and effectiveness drug trials in pediatric age group. Pediatricians have to rely on their personal judicial use of medications in children. We studied off-label use of ursodeoxycholic acid (UDCA) retrospe...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Kotb, Magd Ahmed, Mosallam, Dalia, Basanti, Christine William Shaker, El Sorogy, Sally Talaat Mostafa, Badr, Ahmed M., Abd El Baky, Hend El Hosainy, Draz, Iman Hassan
Formáid: Online Alt Téacs
Teanga:English
Foilsithe / Cruthaithe: Wolters Kluwer Health 2020
Ábhair:
4500
Rochtain ar líne:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035015/
https://www.ncbi.nlm.nih.gov/pubmed/32049781
http://dx.doi.org/10.1097/MD.0000000000018730

Ar líne

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035015/
https://www.ncbi.nlm.nih.gov/pubmed/32049781
http://dx.doi.org/10.1097/MD.0000000000018730

Míreanna comhchosúla